CIK 0001534120
- Non-accelerated filer
- Smaller reporting company
Avalo Therapeutics, Inc.
Sign in to watch- Ticker
- AVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450705648
- Phone
- +1 410-522-8707
- Business address
- 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
- Former names
- Cerecor Inc.
- 4 Open-market buy 10% owner bought 1,608,000 shares at an average $0.64 ($1,030,179)
- 4 Open-market buy 10% owner bought 8,160 shares at an average $3.88 ($31,644)
- 4 Open-market buy 10% owner bought 16,899 shares at an average $3.77 ($63,629)
- 4 Open-market buy Chief Financial Officer bought 511 shares at $3.42 ($1,748)
- 4 Open-market buy CEO and Chairman of the Board bought 4,000 shares at $3.42 ($13,680)
- 4 Open-market buy 10% owner bought 14,426 shares at an average $3.91 ($56,440)
- 4 Open-market buy 10% owner bought 844 shares at $2.87 ($2,422)
- 4 Open-market buy 10% owner bought 2,671 shares at an average $2.79 ($7,464)
- 4 Open-market buy 10% owner bought 9,000 shares at an average $2.98 ($26,816)
- 4 Open-market buy 10% owner bought 26,621 shares at an average $3.36 ($89,372)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 4,379 shares at an average $2.51 ($11,007)
- 4 Open-market buy 10% owner bought 25,000 shares at an average $2.77 ($69,365)
- 4 Open-market buy 10% owner bought 7,500 shares at an average $2.99 ($22,423)
- 4 Open-market buy 10% owner bought 17,500 shares at an average $3.07 ($53,672)
- 4 Open-market buy 10% owner bought 25,000 shares at an average $2.95 ($73,874)
- 4 Open-market buy 10% owner bought 56,329 shares at an average $2.53 ($142,516)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 28 · 552 filings